CJC-1295 / Ipamorelin

CJC-1295 / Ipamorelin is a dual-peptide formulation combining two structurally distinct research compounds used in laboratory studies of peptide signaling and growth hormone-related molecular pathways.

CJC-1295 is a synthetic analog derived from human growth hormone-releasing factor (hGRF). Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 and is classified as a growth hormone secretagogue.

Because these compounds have different structures and interact with distinct signaling mechanisms, the combination provides researchers with a defined formulation for biochemical, receptor-focused, and peptide interaction studies.

Product Details

• Compounds: CJC-1295 and Ipamorelin
• CJC-1295 classification: Synthetic hGRF analog
• Ipamorelin classification: Synthetic pentapeptide
• Ipamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Ipamorelin CAS: 170851-70-4
• CJC-1295 CAS: 446262-90-4
• Form: Research peptide blend
• Intended use: Laboratory and analytical research